Clinical trial
Effect of Tiotropium on Inflammation and Exacerbations in COPD
NCT00405236 · Royal Free and University College Medical School, Other · Completed
Key facts
| NCT number | NCT00405236 |
|---|---|
| Title | Effect of Tiotropium on Inflammation and Exacerbations in COPD |
| Official title | A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Changes in Inflammatory Markers in Induced Sputum Following Treatment With Tiotropium Inhalation Capsules 18mcg Once Daily in Patients With Chronic Obstructive Pulmonary Disease |
| Lead sponsor | Royal Free and University College Medical School, Other |
| Collaborators | Boehringer Ingelheim Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Obstructive Pulmonary Disease |
| Intervention type | Drug |
| Interventions | tiotropium |
| Enrollment | 220 |
| Start date | Oct 1, 2002 |
| Completion | Jan 1, 2005 |
| First posted | Nov 29, 2006 |
| Last update posted | Nov 29, 2006 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: